Heart Failure
📧 Sign up to get email alerts when something new happens for Heart Failure.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-01-07FDA Approved: METOLAZONE — Supplemental Application (Method Pharmaceuticals, LLC)
The FDA approved a supplemental application for METOLAZONE submitted by Method Pharmaceuticals, LLC.
-
FDA approval · 2025-12-22FDA Approved: FUROSCIX — Supplemental Application (scPharmaceuticals Inc.)
The FDA approved a supplemental application for FUROSCIX (furosemide injection 80 mg/10 mL) from scPharmaceuticals Inc.
-
FDA approval · 2025-12-04FDA Approved: EPLERENONE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved Rising Pharma Holdings, Inc.'s supplemental application for eplerenone (ANDA 214663), authorizing changes to the approved gener…
-
EMA approval · 2025-11-17EMA Authorised: Ivabradine Anpharm (ivabradine) — "Anpharm" Przedsiębiorstwo Farmaceutyczne S.A.
The European Medicines Agency authorised a new ivabradine product, Ivabradine Anpharm, by Anpharm Przedsiębiorstwo Farmaceutyczne S.A., for …
-
EMA approval · 2025-11-17EMA Authorised: Corlentor (ivabradine hydrochloride) — Les Laboratoires Servier
The EMA authorised Corlentor (ivabradine hydrochloride) for use in angina pectoris and heart failure. Les Laboratoires Servier is the market…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2025-11-17EMA Authorised: Procoralan (ivabradine hydrochloride) — Les Laboratoires Servier
The European Medicines Agency has granted marketing authorization for Procoralan (ivabradine hydrochloride) for angina pectoris and heart fa…
-
FDA approval · 2025-11-14FDA Approved: ALDACTONE — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approves a supplemental application for Aldactone (spironolactone) from Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2025-11-14FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application from Prasco Laboratories for Spironolactone and Hydrochlorothiazide, a combination diuretic. This re…
-
EMA approval · 2025-10-21EMA Authorised: Aqumeldi (Enalapril (maleate)) — Proveca Pharma Limited
Aqumeldi, containing enalapril maleate, has been authorised by EMA for the treatment of heart failure; the marketing authorization holder is…
-
FDA approval · 2025-10-09FDA Approved: LANOXIN — Supplemental Application (Covis Pharma US, Inc)
The FDA approved Covis Pharma US, Inc.'s supplemental application for LANOXIN (digoxin), authorizing changes to the product as part of an ap…
-
FDA approval · 2025-10-07FDA Approved: LASIX ONYU — Original Application (SQ Innovation, Inc.)
FDA approves LASIX ONYU for the same active ingredient furosemide under an Original Application by SQ Innovation, Inc. The product is now au…
-
FDA approval · 2025-09-12FDA Approved: ENBUMYST — Original Application (Corstasis USA LLC)
The FDA approves ENBUMYST (bumetanide) from Corstasis USA LLC via its Original Application (NDA219500).
-
FDA approval · 2025-09-08FDA Approved: FUROSEMIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for furosemide from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., updating/expandin…
-
FDA approval · 2025-09-02FDA Approved: MILRINONE LACTATE IN 5% DEXTROSE — Original Application (Caplin Steriles Limited)
FDA approved Caplin Steriles Limited's milrinone lactate in 5% dextrose injection as a generic product (ANDA 219170) for the short-term trea…
-
FDA approval · 2025-08-06FDA Approved: FUROSEMIDE — Supplemental Application (Meitheal Pharmaceuticals Inc.)
FDA approved a supplemental application for the generic diuretic furosemide from Meitheal Pharmaceuticals Inc. under ANDA 212803.
-
FDA approval · 2025-07-25FDA Approved: SPIRONOLACTONE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' generic spironolactone under an original application (ANDA 217761).
-
FDA approval · 2025-07-23FDA Approved: VOSTALLY — Original Application (Rosemont Pharmaceuticals LLC)
The FDA approved VOSTALLY (ramipril) from Rosemont Pharmaceuticals LLC through an original application, introducing a branded ramipril produ…
-
FDA approval · 2025-07-17FDA Approved: FUROSEMIDE — Original Application (Aurobindo Pharma Limited)
FDA approves Aurobindo Pharma Limited's original ANDA for furosemide, a generic loop diuretic. The approval covers the generic product for i…
-
EMA approval · 2025-07-17EMA Authorised: Ivabradine Zentiva (ivabradine hydrochloride) — Zentiva, k.s.
The EMA authorised Ivabradine Zentiva (ivabradine hydrochloride) for use in angina pectoris and heart failure; Marketing authorization holde…
-
FDA approval · 2025-07-17FDA Approved: SACUBITRIL AND VALSARTAN — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' original-application generic sacubitril/valsartan for the treatment of heart failure.
-
FDA approval · 2025-07-16FDA Approved: SACUBITRIL AND VALSARTAN — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved the original application (ANDA213748) for a generic sacubitril/valsartan combination from Novadoz Pharmaceuticals LLC.
-
FDA approval · 2025-07-16FDA Approved: SACUBITRIL AND VALSARTAN — Original Application (Novugen Pharma (USA) LLC)
FDA approved the original application for a generic Sacubitril and Valsartan product by Novugen Pharma (USA) LLC, enabling a generic version…
-
FDA approval · 2025-06-24FDA Approved: CARVEDILOL PHOSPHATE — Supplemental Application (AvKARE)
FDA approved a supplemental application for carvedilol phosphate submitted by AvKARE. This action approves a generic carvedilol phosphate pr…
-
FDA approval · 2025-06-13FDA Approved: BUMETANIDE — Supplemental Application (Qilu Pharmaceutical Co., Ltd.)
FDA approved a supplemental application for bumetanide from Qilu Pharmaceutical Co., Ltd., authorizing the generic product's approval.
-
FDA approval · 2025-06-05FDA Approved: MILRINONE LACTATE — Supplemental Application (Shandong New Time Pharmaceutical Co., Ltd.)
FDA approved a supplemental ANDA for milrinone lactate from Shandong New Time Pharmaceutical Co., Ltd., authorizing the generic product for …